#5e2d92_SMALL_Nov-Dec 2024 DRA Journal Cover

From myth-busting photobiomodulation therapy to showcasing advanced aesthetic cases, this issue delivers practical insights for modern dental practice. Explore evidence-based techniques in implant and veneer rehabilitation, essential guidance on monkeypox protocols, and strategies for enhanced patient communication.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

Dental Biomaterials Market Set to Achieve $15.8 Billion by 2030

The global dental biomaterials market, valued at US$8.6 billion in 2022, is expected to witness substantial growth, reaching a projected size of US$15.8 billion by 2030. 

This growth is projected to occur at a compounded annual growth rate (CAGR) of 7.9% during the analysis period from 2022 to 2030.

Noteworthy Segments: Ceramic and Metallic

Among the segments analysed in the report, ceramic is expected to experience significant growth, with a projected CAGR of 7.5%. By the end of the analysis period, the ceramic segment is estimated to reach US$5.5 billion. 

Additionally, the metallic segment is anticipated to grow at a revised CAGR of 7.6% for the next eight years, considering the ongoing post-pandemic recovery.

China and US Global Market Leaders

The United States holds a prominent position in the dental biomaterials market, with an estimated value of US$2.3 billion in 2022. 

However, China, the world’s second-largest economy, is projected to witness substantial growth, reaching a market size of US$3.5 billion by 2030. The Chinese market is anticipated to trail a remarkable CAGR of 11.7% during the period from 2022 to 2030.

Several other geographic markets also show promising growth prospects. Japan and Canada are both expected to grow, with forecasted CAGRs of 4.6% and 7.1%, respectively, over the period from 2022 to 2030. 

Within Europe, Germany is projected to witness growth at an approximate CAGR of 5.2%.

Key Competitors in the Market

The dental biomaterials market features a competitive landscape with several leading players. Some of the notable companies include 3M Company, Bego Medical GmbH, Cam Bioceramics B.V., Carpenter Technology Corporation, Danaher Corporation, Datum Dental Ltd., Dentsply Sirona, Inc., GC Corporation, Geistlich Pharma AG, Henry Schein, Inc., Ivoclar Vivadent AG, Keystone Dental, Inc., Kuraray Co., Ltd., Medtronic PLC, Mitsui Chemicals, Inc., Royal DSM, Straumann Holding AG, Victrex PLC, and Zimmer Biomet Holdings, Inc.

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

2 thoughts on “Dental Biomaterials Market Set to Achieve $15.8 Billion by 2030

Leave a Reply

Your email address will not be published. Required fields are marked *